Despite the fast development of technology in the world, diabetic foot wounds cause deaths and massive economical losses. Diabetes comes first among the reasons of non traumatic foot amputations. To reduce the healing time of these fast progressing wounds, effective wound dressings are in high demand. In our study, sheep small intestinal submucosa (SIS) based biocompatible sponges were prepared after SIS decellularization and their wound healing potential was investigated on full thickness skin defects in a diabetic rat model. The decellularized SIS membranes had no cytotoxic effects on human fibroblasts and supported capillary formation by HUVECs in a fibroblast-HUVEC co-culture. Glutaraldehyde crosslinked sponges of three different compositions were prepared to test in a diabetic rat model: gelatin (GS), gelatin: hyaluronic acid (GS:HA) and gelatin: hyaluronic acid: SIS (GS:HA:SIS). The GS:HA:SIS sponges underwent a 24.8 ± 5.4% weight loss in a 7-day in vitro erosion test. All sponges had a similar Young’s modulus under compression but GS:HA:SIS had the highest (5.00 ± 0.04 kPa). Statistical analyses of histopathological results of a 12-day in vivo experiment revealed no significant difference among the control, GS, GS:HA, and GS:HA:SIS transplanted groups in terms of granulation tissue thickness, collagen deposition, capillary vessel formation, and foreign body reaction (P > 0.05). On the other hand, in the GS:HA:SIS transplanted group 80% of the animals had a complete epidermal regeneration and this was significantly different than the control group (30%, P < 0.05). Preclinical studies revealed that the ECM of sheep small intestinal submucosa can be used as an effective biomaterial in diabetic wound healing.
TurnerNJBadylakSF.The use of biologic scaffolds in the treatment of chronic nonhealing wounds. Adv Wound Care2015;
4: 490–500.
2.
BaltzisDEleftheriadouIVevesA.Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther2014;
31: 817–836.
3.
MouraFDiasACarvalhoE, et al.
Recent advances on the development of wound dressings for diabetic foot ulcer treatment – a review. Acta Biomater2013;
9: 7093–7114.
4.
WangWLinSXiaoY, et al.
Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci2008;
82: 190–204.
5.
LuoJCChenWChenXH, et al.
Multi-step method for preparation of porcine small intestinal submucosa (SIS). Biomaterials2011;
32: 706–713.
6.
KimMSHongKDShinHW, et al.
Preparation of porcine small intestinal submucosa sponge and their application as a wound dressing in full-thickness skin defect of rat. Int J Biol Macromol2005;
36: 54–60.
7.
LambaNMKWoodhouseKACopperSL.Polyurethane in biomedical applications. 1st ed.Boca Raton:
CRC Press, 1997.
8.
CaoGHuangYLiK, et al.
Small intestinal submucosa: superiority, limitations and solutions, and potential to address bottlenecks in tissue repair. J Mater Chem B2019;
7: 5038–5055.
9.
AhnHHKimKSLeeJH, et al.
Porcine small intestinal submucosa sheets as a scaffold for human bone marrow stem cells. Int J Biol Macromol2007;
41: 590–596.
10.
GuoXXiaBLuXB, et al.
Grafting of mesenchymal stem cell-seeded small intestinal submucosa to repair the deep partial-thickness burns. Connect Tissue Res2016;
57: 388–397.
11.
RashtbarMHadjatiJAiJ, et al.
Critical-sized full-thickness skin defect regeneration using ovine small intestinal submucosa with or without mesenchymal stem cells in rat model. J Biomed Mater Res Part B Appl Biomater2018;
106: 2177–2190.
12.
ParmaksizMElcinAEElcinYM.Decellularization of bovine small intestinal submucosa and its use for the healing of a critical-sized full-thickness skin defect, alone and in combination with stem cells, in a small rodent model. J Tissue Eng Regenerative Med2015;
49: 337–339.
13.
ZhaoPLiXFangQ, et al.
Surface modification of small intestine submucosa in tissue engineering. Regen Biomater2020;
7: 339–348.
14.
WangLWangWLiaoJ, et al.
Novel bilayer wound dressing composed of SIS membrane with SIS cryogel enhanced wound healing process. Mater Sci Eng C Mater Biol Appl2018;
85: 162–169.
15.
AyB.Skeletal muscle tissue formation potential of asellular skeletal muscle originated native and semi-syntetic scaffolds loaded with human myoblasts and mesenchymal stem cells. Master Thesis, Kocaeli University, Institute of Health Sciences, Kocaeli, 2012.
16.
GilbertTWFreundJMBadylakSF.Quantification of DNA in biologic scaffold materials. J Surg Res2009;
152: 135–139.
17.
WangH-MChouY-TWenZ-H, et al.
Novel biodegradable porous scaffold applied to skin regeneration. PLoS One2013;
8: e56330.
18.
KenarH.3D patterned cardiac tissue construct formation using biodegradable materials. Doctoral Thesis, Middle East Technical University, Natural And Applied Sciences, Ankara, 2008.
19.
SyedOWaltersNJDayRM, et al.
Evaluation of decellularization protocols for production of tubular small intestine submucosa scaffolds for use in oesophageal tissue engineering. Acta Biomater2014;
10: 5043–5054.
20.
TomihataKIkadaY.Crosslinking of hyaluronic acid with glutaraldehyde. J Polym Sci A Polym Chem1997;
35: 3553–3559.
21.
LondonoRBadylakSF.Biologic scaffolds for regenerative medicine: mechanisms of in vivo remodeling. Ann Biomed Eng2015;
43: 577–592.
22.
UrciuoloFCasaleCImparatoG, et al.
Bioengineered skin substitutes: the role of extracellular matrix and vascularization in the healing of deep wounds. JCM2019;
8: 2083.
23.
DickinsonLEGerechtS.Engineered biopolymeric scaffolds for chronic wound healing. Front Physiol2016;
7: 341.
24.
DzoboKMotaungKSCMAdesidaA.Recent trends in decellularized extracellular matrix bioinks for 3D printing: an updated review. IJMS2019;
20: 4628.
25.
MostowENHarawayGDDalsingM, OASIS Venus Ulcer Study Groupet al.
Effectiveness of an extracellular matrix graft (OASIS wound matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg2005;
41: 837–843.
26.
Barendse-HofmannMGSteenvoordePVan DoornL, et al.
Extracellular wound matrix (OASIS®): exploring the contraindications. Results of its use in 32 consecutive outpatient clinic cases. Wounds2007;
19: 258–263.
27.
GilpinAYangY.Decellularization strategies for regenerative medicine: from processing techniques to applications. BioMed Res Int2017;
2017: 9831534.
28.
TotteySJohnsonSACrapoPM, et al.
The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials2011;
32: 128–136.
29.
Parmaksiz M, Elcin A and Elcin Y. Decellularization of bovine small intestinal submucosa. In: Turksen K (eds) Decellularized Scaffolds and Organogenesis: Methods and Protocols. Methods in Molecular Biology, vol 1577. New York, NY: Humana Press, 2018, pp.129–138.
30.
MalcarneyHLBonarFMurrellGAC.Early inflammatory reaction after rotator cuff repair with a porcine small intestine submucosal implant: a report of 4 cases. Am J Sports Med2005;
33: 907–911.
31.
ZhengM-HChenJKirilakY, et al.
Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation. J Biomed Mater Res Part B: Appl Biomater2005;
73: 61–67.
32.
ZhangXFangZChoE, et al.
Use of a novel, reinforced, low immunogenic, porcine small intestine submucosa patch to repair a supraspinatus tendon defect in a rabbit model. BioMed Res Int2019;
2019: 9346567.
33.
AamodtJMGraingerDW.Extracellular matrix-based biomaterial scaffolds and the host response. Biomaterials2016;
86: 68–82.
34.
AuroraAMcCarronJIannottiJP, et al.
Commercially available extracellular matrix materials for rotator cuff repairs: state of the art and future trends. J Shoulder Elbow Surg2007;
16: S171–171S8S.
35.
DerwinKABakerARSpraggRK, et al.
Commercial extracellular matrix scaffolds for rotator cuff tendon repair. Biomechanical, biochemical, and cellular properties. J Bone Joint Surg Am2006;
88: 2665–2672.
MilanPBLotfibakhshaieshNJoghataieMT, et al.
Accelerated wound healing in a diabetic rat model using decellularized dermal matrix and human umbilical cord perivascular cells. Acta Biomater2016;
45: 234–246.
38.
KolluruGKBirSCKevilCG.Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med2012;
2012: 918267.
39.
FalangaV.Wound healing and its impairment in the diabetic foot. Lancet2005;
366: 1736–1743.
40.
KohTJDiPietroLA.Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med2011;
13: e23.
41.
ZhouKMaYBroganMS.Chronic and non-healing wounds: the story of vascular endothelial growth factor. Med Hypotheses2015;
85: 399–404.
42.
WilgusTA.Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol Res2008;
58: 112–116.
43.
Voytik-HarbinSLSherryLBrightmanAO, et al.
Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem1997;
67: 478–491.
44.
PradhanLAndersenNDNabzdykC, et al.
Wound-healing abnormalities in diabetes and new therapeutic interventions. US Endocrinol2007;
1: 68–72.
45.
AyaKLSternR.Hyaluronan in wound healing: rediscovering a major player. Wound Repair Regen2014;
22: 579–593.
46.
DunphyJEUdupaKN.Chemical and histochemical sequences in the normal healing of wounds. N Engl J Med1955;
253: 847–851.
PerngCKWangYJTsiCH, et al.
In vivo angiogenesis effect of porous collagen scaffold with hyaluronic acid oligosaccharides. J Surg Res2011;
168: 9–15.
49.
QuanRZhengXXuS, et al.
Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a three-dimensional skin substitute. Stem Cell Res Ther2014;
5: 118–137.
50.
UlubayramKAksuEGurhanSID, et al.
Cytotoxicity evaluation of gelatin sponges prepared with different cross-linking agents. J Biomater Sci Polymer Edn2002;
13: 1203–1219.
51.
UlubayramKErogluIHasirciN.Gelatin microspheres and sponges for delivery of macromolecules. J Biomater Appl2002;
16: 227–241.
52.
BilgicHDemirizMOzlerM, et al.
Effects of EGF containing gelatin sponges as wound healing scaffolds. j Biomat Tissue Engng2013;
3: 205–211.
53.
DhandayuthapaniBYoshidaYMaekawaT, et al.
Polymeric scaffolds in tissue engineering application: a review. Int J Polym Sci2011;
2011: 1–19.
54.
VacantiCA.The history of tissue engineering. J Cell Mol Med2006;
10: 569–576.
55.
SaltzmanMWKyriakidesTR.Cell interactions with polymers principles of tissue engineering.
Vol. 20. 4th ed.
Amsterdam:
Elsevier Academic Press, 2014, pp.385–406.
56.
ValentinJEBadylakJSMcCabeGP, et al.
Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am2006;
88: 2673–2686.
